Drug intelligence / Profile preview

Midaform insulin

Development stage
Unknown
Lead developer
MidaSol Therapeutics
Modality
Nanoparticles → Drug Delivery Systems, Recombinant Proteins and Enzymes
Administration
Transbuccal
01

Overview

Midaform insulin is a proprietary nanoformulated insulin delivery system consisting of recombinant human insulin non-covalently bound to glycan-coated gold nanoparticles and embedded in a rapidly dissolving mucoadhesive PharmFilm placed on the inside of the cheek for transbuccal absorption. Developed by Midatech using its Midaform gold nanoparticle technology and MonoSol Rx's PharmFilm platform, licensed to their joint venture MidaSol Therapeutics, it mimics pancreatic monomeric insulin release with faster onset than subcutaneous injection, aiming to provide a needle-free alternative for diabetes management, particularly postprandial hyperglycemia.[2][3][5]

Brand names
Midaform Insulin PharmFilm
Other names
transbuccal insulinbuccally administered oral insulin film
02

Targets

INSR (Insulin receptor)

Beyond the preview

Go deeper on Midaform insulin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Midaform insulin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call